CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

MAXAM Tire

MAXAM Tire North America is a global leader and manufacturer of specialty tires engineered and custom built specifically for OTR, construction, industrial and agricultural industries. MAXAM Tire has over 50+ years experience in designing, distributing and engineering high-quality specialty tires for markets all around the world. When it comes to serving customers, we deliver unmatched business solutions, service and support. Learn more at www.maxamtire.com

Perimeter Solutions

Perimeter Solutions is a global specialty chemicals company based in Clayton, Missouri, established in 1963. The company focuses on two main areas: fire safety solutions and lubricant additives. It is a market leader in both sectors, particularly known for its wildfire retardants, firefighting foams, and industrial fire suppressants. Perimeter Solutions offers a range of products, including water-enhancing gels and preventative fire retardants, catering to government agencies, municipalities, and industrial clients worldwide. In addition to fire safety, Perimeter Solutions specializes in niche engine oil additives, holding a significant market share in this area. These additives improve lubricant performance for both automotive and industrial applications. The company is publicly traded under the ticker PRM and is co-founded by Nick Howley, who also chairs the company. With a strong emphasis on innovation and a robust manufacturing and distribution network, Perimeter Solutions positions itself as a premier provider of chemical solutions in its industries.

Hal Smith Restaurants

Hal Smith Restaurants is a restaurant management company based in Norman, Oklahoma, founded in 1992 by Hal Smith. The company operates over 80 locations across seven states, featuring a diverse range of dining options from casual to upscale. Annual sales approach $250 million, and the company emphasizes strong customer service and employee training. The company develops, manages, and franchises various restaurant concepts. Its portfolio includes full-service dining options like Charleston’s Restaurant, Red Rock Canyon Grill, and Mahogany Prime Steakhouse. It also features casual and themed concepts such as Ted’s Café Escondido, Louie’s Bar & Grill, The Garage, and Pub W. Hal Smith Restaurants has a history of franchising, having previously managed Outback Steakhouse and On The Border Mexican Cafe franchises. With a focus on community-centric locations, Hal Smith Restaurants continues to expand, including new openings like Neighborhood JA.M. in Oklahoma City planned for Spring 2025. The company is dedicated to culinary excellence and creating memorable dining experiences for a wide range of customers.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.